Evidence map›Paper›PMID 41327621›Full record

ArticleCurrent medical imaging2026

1H MR Spectroscopy at 3T for Hepatic Choline Quantification in Healthy Young Women: A Translational Imaging Study with Dietary Correlation.

Halima Hawesa, Renad Alghamdi, Hind Allam, Bayader Alfaifi, Norah Alrabiah, Mayar Alghumaiz, Mansour Shanawani, Haya Alshegri, Mahasin G Hassan

Abstract read
In one paragraph

Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Halima HawesaDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Renad AlghamdiDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Hind AllamDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Bayader AlfaifiDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Norah AlrabiahDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Mayar AlghumaizDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Mansour ShanawaniDepartment of Radiology, King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
Haya AlshegriDepartment of Radiology, King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
Mahasin G HassanDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-invasive biomarkers of liver metabolism are essential for early detection of metabolic alterations. Choline plays a central role in hepatic function, yet its dietary intake and imaging correlates remain underexplored. This study evaluated the feasibility of proton Magnetic Resonance Spectroscopy (1H-MRS) at 3T for hepatic choline quantification and examined its correlation with dietary intake in young women, a population at risk of nutrient-sensitive liver conditions.

methodsIn this prospective cohort study, 88 healthy female radiology students (mean age: 21.4 ± 1.8 years) underwent single-voxel 1H-MRS of the liver using a 3T Siemens Magnetom Vida scanner. Spectra were acquired with a point-resolved spectroscopy (PRESS) sequence (TR = 2000 ms, TE = 40 ms, voxel size = 20 × 20 × 20 mm3), with automated shimming and unsuppressed water referencing. Spectral analysis was performed using LCModel (v6.3), applying quality thresholds (Signal-to-Noise Ratio (SNR) > 5, linewidth < 0.1 ppm, Cramér–Rao Lower Bound (CRLB) < 20%. Hepatic choline concentrations were expressed in Institutional Units (IU). Dietary intake was assessed using a validated Food Frequency Questionnaire (FFQ).

resultsHigh-quality spectra were consistently obtained (mean SNR: 12.6 ± 3.1; linewidth: 0.048 ± 0.012 ppm). Mean hepatic choline concentration was 4.63 ± 1.21 IU, while mean dietary intake was 29.1 ± 8.7 mg/day. A significant positive correlation was observed (r = 0.555, p < 0.001). Regression analysis confirmed dietary intake as a significant predictor (β = 0.56, R2 = 0.308, p < 0.001). Discussion: These findings demonstrate that ¹H MRS at 3T provides reproducible hepatic choline quantification and captures meaningful variability linked to dietary intake. The observed correlation highlights the potential of MRS as a translational biomarker of nutrient related liver metabolism. Integrating MRS into multiparametric liver imaging protocols may enhance early detection of metabolic alterations and broaden the scope of noninvasive liver assessment.

conclusion1H-MRS at 3T is a feasible and reproducible technique for hepatic choline quantification. By measuring metabolites directly in the liver at their site of production, rather than in circulation, where concentrations may be altered, MRS provides physiologically relevant insights into nutrient-related hepatic metabolism. Its correlation with dietary intake highlights its potential as a translational imaging biomarker for early detection and risk stratification of nutrient-sensitive liver conditions.

Indexed as

CholineDietLiverProton Magnetic Resonance SpectroscopyAdultBiomarkersFeasibility StudiesFemaleHumansProspective StudiesTranslational Research, BiomedicalYoung AdultBiomarkersCholineDietary choline intakeHepatic cholineIn vivo metabolite quantificationMultiparametric liver MRINutrient-sensitive liver conditionsProton Magnetic Resonance Spectroscopy (1H-MRS)Tissue-level biomarkersTranslational metabolic imaging.

Identifiers

PMID41327621
PMCPMC13312383

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.